LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.31623
80.31 27.76 195 6976 0.0280 0.2770
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
80.31 27.76 1162 6976 0.1666 0.5974
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
80.31 27.76 160 6976 0.0229 0.2457
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
80.31 27.76 1420 6976 0.2036 0.6380
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
82.01 27.76 202 7000 0.0289 0.2824
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
82.01 27.76 1227 7000 0.1753 0.6078
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
82.01 27.76 157 7000 0.0224 0.2426
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
82.01 27.76 1401 7000 0.2001 0.6348
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
83.72 27.76 207 7055 0.0293 0.2859
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
83.72 27.76 1151 7055 0.1631 0.5939
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
83.72 27.76 183 7055 0.0259 0.2662
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
83.72 27.76 1406 7055 0.1993 0.6344
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
85.42 27.76 230 7025 0.0327 0.3033
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
85.42 27.76 1337 7025 0.1903 0.6247
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
85.42 27.76 175 7025 0.0249 0.2594
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
85.42 27.76 1522 7025 0.2166 0.6513
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
87.13 27.76 264 6987 0.0378 0.3263
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
87.13 27.76 1265 6987 0.1810 0.6142
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
87.13 27.76 180 6987 0.0258 0.2641
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
87.13 27.76 1347 6987 0.1928 0.6270
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
88.84 27.76 262 6965 0.0376 0.3253
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
88.84 27.76 1241 6965 0.1782 0.6108
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
88.84 27.76 200 6965 0.0287 0.2811
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
88.84 27.76 1531 6965 0.2198 0.6538
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
90.55 27.76 276 6928 0.0398 0.3343
MN20160318_Q01
H15